This suggests that the presence of TP53 abnormalities enables CLL cells to partially bypass the requirement for BCR-signaling to induce metabolic reprogramming, with these cells becoming less dependent on microenvironment stimuli. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.